Entero Therapeutics, Inc. (ENTO) — Cash Flow Reinvestment Rate
Entero Therapeutics, Inc. (ENTO) has a Cash Flow Reinvestment Rate of 0.00x as of June 2014, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $129.24. See Entero Therapeutics, Inc. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Entero Therapeutics, Inc. Cash Flow Reinvestment Rate (2013–2013)
Historical reinvestment intensity for Entero Therapeutics, Inc. across 1 annual periods. For the full cash flow conversion analysis, see Entero Therapeutics, Inc. cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Entero Therapeutics, Inc. (2013–2013)
Year-by-year capital reinvestment analysis for Entero Therapeutics, Inc.. See ENTO free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2013 | 0.00x | $0.00 | $56.55 | $0.00 | — |